Jennifer Buenviaje
机构:Bristol-Myers Squibb (United States)
发表论文 9 篇 · 总被引 243 次 · h-index 5
代表论文
- KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission (2014 · Antimicrobial Agents and Chemotherapy · 被引 158)
- Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation (2023 · Journal of Medicinal Chemistry · 被引 53)
- Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2) (2023 · Journal of Medicinal Chemistry · 被引 12)
- Development of a Buchwald–Hartwig Amination for an Accelerated Library Synthesis of Cereblon Binders (2024 · ACS Medicinal Chemistry Letters · 被引 10)
- Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment (2024 · ACS Medicinal Chemistry Letters · 被引 8)
- Abstract 6378: Brain-penetrant molecular glue degraders targeting ALK via a novel degron: a potential therapeutic approach for ALK-positive NSCLC (2025 · Cancer Research · 被引 2)